Skip to main content
Log in

Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium

  • ONCOLOGY
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Malignant gliomas are most common and fatal primary brain tumors. In addition to neoplastic cells, the tumor tissue contains microglial cells and monocyte-derived macrophages. It is an established fact that monocyte recruiting promotes the tumor growth and dissemination. Monocyte chemotactic protein-1 (MCP-1) is the major attractant for monocytes. We have previously synthesized an MCP-1 antagonist ingramon, a synthetic peptide fragment (65–76) of this chemokine. In the present study, we demonstrated that glioma-conditioned medium contains MCP-1 and stimulates migration of blood monocytes. Ingramon inhibited the effect of glioma-conditioned medium on monocyte migration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. N. B. Kukhtina, T. I. Arefi eva, and T. L. Krasnikova, Biokhimiya, 70, No. 6, 790–795 (2005).

  2. T. I. Arefi eva, T. L. Krasnikova, A. V. Potekhina, et al., Infl amm. Res., 60, No. 10, 955–964 (2011).

  3. N. A. Charles, E. C. Holland, R. Gilbertson, et al., Glia, 59, No. 8, 1169–1180 (2011).

    Article  PubMed  Google Scholar 

  4. A. C. da Fonseca and B. Badie, Clin. Dev. Immunol., 2013, 264124 (2013).

    PubMed  Google Scholar 

  5. I. Desbaillets, M. Tada, N. de Tribolet, et al., Int. J. Cancer., 58, No. 2, 240–247 (1994).

    Article  CAS  PubMed  Google Scholar 

  6. U. M. Domanska, R. C. Kruizinga, W. F. den Dunnen, et al., Crit. Rev. Oncol. Hematol., 79, No. 2, 154–163 (2011).

    Article  CAS  PubMed  Google Scholar 

  7. S. Han, C. Zhang, Q. Li, et al., Br. J. Cancer., 110, No. 10, 2560–2568 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. S. V. Kushchayev, T. Sankar, L. L. Eggink, et al., Cancer Manag. Res., 4, 309–323 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Y. Lin, G. Zhang, Y. Zhang, et al., J. Neurooncol., 114, No. 2 , 199–208 (2013).

    Article  CAS  PubMed  Google Scholar 

  10. Y. C. Ooi, P. Tran, N. Ung, et al., Clin. Neurol. Neurosurg., 119, 125–132 (2014).

    Article  PubMed  Google Scholar 

  11. M. Platten, A. Kretz, U. Naumann, et al., Ann. Neurol., 54, No. 3, 388–392 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. C. Vasco, A. Canazza, A. Rizzo, et al., J. Neurooncol., 115, No. 3, 353–363 (2013).

    Article  CAS  PubMed  Google Scholar 

  13. J. Zang, S. Sarkar, R. Cua, et al., Carcinogenesis, 33, No. 2, 312–319 (2012).

    Article  Google Scholar 

  14. X. Zhu, M. Fujita, L. A. Snyder, and H. Okada, J. Neurooncol., 104, No. 1, 83–92 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. L. Krasnikova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 160, No. 10, pp. 484–487, October, 2015

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krasnikova, T.L., Arefieva, T.I., Pylaeva, E.A. et al. Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium. Bull Exp Biol Med 160, 480–482 (2016). https://doi.org/10.1007/s10517-016-3201-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3201-0

Key Words

Navigation